Telephone Follow up and Gestational Diabetes

• Register: IRCT
• Last refreshed on: 22 February 2018
• Main ID: IRCT138904143037N3
• Date of registration: 2012-06-06
• Prospective Registration: No
• Primary sponsor: Tehran University of Medical Science
• Public title: Telephone Follow up and Gestational Diabetes
• Scientific title: Effect of telephone follow up on pregnancy outcome and general health of mothers with Gestational Diabetes
• Date of first enrolment: 2011-07-11
• Target sample size: 80
• Recruitment status: Complete
• URL: http://en.irct.ir/trial/3044
• Study type: interventional
• Study design: Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Single, Purpose: Supportive.
• Phase: N/A

Countries of recruitment

Iran (Islamic Republic of)

Contacts

• Name: Mehrnaz Geranmayeh
• Affiliation: Tehran University of Medical Science

• Name: Mehrnaz Geranmayeh
• Affiliation: Tehran University of Medical Science

Key inclusion & exclusion criteria

Inclusion criteria: Inclusion Criteria:
Age between 18-45 years
Singleton pregnancy
Not taking medication that increase blood glucose such as corticosteroids
Having phone at home
Not having speech and hearing problems
Being able to speak Persian language and understand it
Lack of chronic diseases
No history of infertility or ART
No history of diabetes in pre pregnancy
Having at least read and write
Exclusion Criteria:
Not respond to phone calls (more than one contact)
The condition that increase blood sugar such as stress, death of relatives and take steroids and other drug
Preterm labor
Use of any diet and medication during study
Exclusion criteria:

Age minimum: 18 years
Age maximum: 45 years
Gender: Female

Health Condition(s) or Problem(s) studied

Gestational Diabetes.
z35

Intervention(s)

Telephone follow up in order to adherence to diet, insulin injections, doctor prescribed, doing lab test and also to remind the next visit and answering patient's questions about pregnancy, diabetes and generel health.

Telephone follow up in order to adherence to diet, insulin injections, doctor prescribed, doing lab test and also to remind the next visit and answering patient's questions about pregnancy, diabetes and generel health..

Primary Outcome(s)

Measuring blood Sugar. Timepoint: 28,32 and 36 weeks of pregnancy. Method of measurement: Exicheck.

Secondary Outcome(s)

Outcome pregnancy and General health. Timepoint: Before and after intervention. Method of measurement: Questionnaire.

Source(s) of Monetary Support

Tehran University of Medical Science

Ethics review

Status: Approved
Approval date:
Contact:

Tehran University of Medical Science